Gilead Sciences Top Holdings and 13F Report (2026) About Gilead SciencesGilead Sciences NASDAQ: GILD has filed 13-F forms with the SEC as an investor. Gilead Sciences is itself a publicly traded company. Gilead Sciences, Inc., founded in 1987 and headquartered in Foster City, California, is a biopharmaceutical company focused on the discovery, development and commercialization of medicines in areas of high unmet medical need. The company initially built its reputation in antiviral therapies and has since expanded into oncology, cell therapy and inflammatory diseases. Gilead operates a global research and commercial organization, conducting clinical development and selling medicines in markets around the world. For more information on Gilead Sciences stock, visit the Gilead Sciences stock profile here.Investment ActivityGilead Sciences has $1.65 billion in total holdings as of June 30, 2026.Gilead Sciences owns shares of 5 different stocks, but just 2 companies or ETFs make up 80% of its holdings.Approximately 0.79% of the portfolio was purchased this quarter.About 46.80% of the portfolio was sold this quarter.This quarter, Gilead Sciences has purchased 6 new stocks and bought additional shares in 1 stock.Gilead Sciences sold shares of 0 stocks and completely divested from 1 stock this quarter.Largest Holdings Arcus Biosciences $968,825,351Lakefront Biotherapeutics $500,157,715Assembly Biosciences Inc. $136,770,406Kyverna Therapeutics Inc. $36,763,720Xilio Therapeutics $6,230,727 Largest Purchases this Quarter Assembly Biosciences Inc. 471,698 shares (about $12.96M) Sector Allocation Over TimeMap of 500 Largest Holdings ofGilead Sciences Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorRCUSArcus Biosciences$968,825,3510.0%31,424,76058.8%HealthcareLakefront Biotherapeutics$500,157,7150.0%16,707,47730.3%SPON ADRAssembly Biosciences Inc.$136,770,406$12,962,261 â–²10.5%4,977,0898.3%COM NEWKyverna Therapeutics Inc.$36,763,7200.0%4,126,1192.2%COMXLOXilio Therapeutics$6,230,7270.0%650,3890.4%HealthcareACLXArcellx$0$771,682,600 â–¼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
